Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

Chief Operations Officer

SVP Finance & Operations

President and CEO

President of R&D

Chief Financial Officer

Chief Scientific Officer

Chief Business Officer

VP Finance & Operations

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-102, a CAR-iT targeting CD19 + CD22 for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-107, an iPSC-derived Nectin-4 CAR gamma delta T-cell therapy product candidate; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor an...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-06	Premium	sold	Premium	Premium	Premium	See Remarks
2024-05-03	Premium	sold	Premium	Premium	Premium	Chief Operations Officer
2024-05-03	Premium	sold	Premium	Premium	Premium	SVP Finance & Operations
2024-04-22	Premium	sold	Premium	Premium	Premium	See Remarks
2024-03-07	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-07	Premium	acquired	Premium	Premium	Premium	Chief Operations Officer
2024-03-07	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-03-07	Premium	acquired	Premium	Premium	Premium	SVP Finance & Operations
2024-03-07	Premium	acquired	Premium	Premium	Premium	President of R&D
2024-03-07	Premium	acquired	Premium	Premium	Premium	Chief Operations Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	Chief Operations Officer
2024-03-06	Premium	acquired	Premium	Premium	Premium	Chief Operations Officer
2024-03-06	Premium	sold	Premium	Premium	Premium	Chief Operations Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Operations Officer
2024-02-16	Premium	acquired	Premium	Premium	Premium	Chief Operations Officer
2024-02-06	Premium	sold	Premium	Premium	Premium	Chief Operations Officer
2024-02-06	Premium	sold	Premium	Premium	Premium	SVP Finance & Operations
2024-02-05	Premium	sold	Premium	Premium	Premium	Chief Operations Officer
2024-02-05	Premium	sold	Premium	Premium	Premium	SVP Finance & Operations
2023-12-04	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-11-01	Premium	sold (taxes)	Premium	Premium	Premium	SVP Finance & Operations
2023-11-01	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-05-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-05-15	Premium	acquired	Premium	Premium	Premium	SVP Finance & Operations
2023-04-03	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer

IPSC - 2 Stock Price, Fair Value and News

Latest Insider Trading transactions for IPSC